Epsilon: from 5th best to outside the top 20 in 12 months

Mr Xu, Mr White and Mr Didugu,

I draw your attention to Business News Australia's annual review of the Australian Cannabis Industry in 2020 (link) and 2021 (link).

In July 2020, the company was ranked 5th in Australia's list of top 20 cannabis companies, up from 10th in the previous year.

A quote from the 2020 publication: "Over the last three years THC has made a name for itself as one of the fastest-moving suppliers of medicinal cannabis in Australia. From growing to manufacturing to distribution, THC is in the driver's seat."

In July 2021, the company did not make the top 20 list.

IMHO this major shift in ranking is not related to the general cannabis industry and changes in investor interest, which would impact other listed companies as well.

The only quote on Epsilon's past 12 months from the 2021 publication was: "THC Global was renamed Epsilon Healthcare (ASX: EPN) to better reflect its broader interests in the healthcare and pharmaceutical market. The falling market value of the company has seen it fall off the list this year."

IMHO it is disappointing that the only activity in 12 months noted by an independent external party was that THC Global changed its company name to Epsilon Healthcare.

The only other companies to fall off the top 20 list were the much lower ranked companies MMJ (15th in 2020) and EVE (16th in 2020).

IMHO it would be appropriate for all three of you to publicly make clear that you have both the ability and the will to address Epsilon's change in standing over the last 12 months.